Craft

MediClin

Stock Price

€2.4

2024-03-28

Market Capitalization

€116.8 M

2024-03-28

Revenue

€704.7 M

FY, 2022

MediClin Summary

Company Summary

Overview
MediClin operates 52 facilities nationwide. This includes hospitals (acute care), rehabilitation clinics, care homes and medical care centres. The Group offers a specialist range of medical services, in particular, in the area of acute care, for example neurosurgery in Plau am See, the heart centres in Coswig and Lahr, early neurological rehabilitation in Lingen, Soltau or Plau am See, or the specialist orthopaedic hospital in Bad Düben. The range of medical services at MediClin is of a high quality and extremely diverse. Specialist disciplines at MediClin have been formed in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry) and orthopaedics. In addition, special expertise can be found in individual locations in the areas of ENT (tinnitus, cochlear implants), oncology (radiotherapy) and inner medicine (e.g. cardiology, pneumology and endocrinology).
Type
Public
Status
Active
HQ
Offenburg, DE | view all locations
Website
https://www.mediclin.de/Home.aspx
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Tino Fritz

    Tino Fritz, CFO & Director

    LocationsView all

    1 location detected

    • Offenburg, Baden-Württemberg HQ

      Germany

      27 Okenstraße

    MediClin Financials

    Summary Financials

    Revenue (Q3, 2023)
    €182.4M
    Gross profit (Q3, 2023)
    €158.9M
    Net income (Q3, 2023)
    €10.5M
    Cash (Q3, 2023)
    €109.6M
    EBIT (Q3, 2023)
    €18.1M
    Enterprise value
    $490.9M

    Footer menu